Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.
Smith MR; McGovern FJ; Zietman AL; Fallon MA; Hayden DL; Schoenfeld DA; Kantoff PW; Finkelstein JS; The New England Journal Of Medicine, 2001, vol. 345, issue 13, p 948, ISSN 00284793. ISBN 00284793.
Full Text Resources Located for this Citation